Garifallia G. Anastopoulou

Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials

Jordi Bruna, Andreas A. Argyriou, Garifallia G. Anastopoulou et al. · Journal of the Peripheral Nervous System · 2020 · 54 citations

Immunodeficiencies, Immunology, Immunoediting +24

Assessing risk factors of falls in cancer patients with chemotherapy-induced peripheral neurotoxicity

Andreas A. Argyriou, Jordi Bruna, Garifallia G. Anastopoulou et al. · Supportive Care in Cancer · 2019 · 28 citations

Fall Prevention, Oncology, Cancer Risk +11

Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study

Andreas A. Argyriou, Jordi Bruna, Foteini Kalofonou et al. · Journal of the Peripheral Nervous System · 2024 · 15 citations

Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity

Andreas A. Argyriou, Foteini Kalofonou, Pantelis Litsardopoulos et al. · Journal of the Peripheral Nervous System · 2020 · 13 citations

Liability of the voltage‐gated potassium channel <i>KCNN3</i> repeat polymorphism to acute oxaliplatin‐induced peripheral neurotoxicity

Andreas A. Argyriou, Anna G. Antonacopoulou, Paola Alberti et al. · Journal of the Peripheral Nervous System · 2019 · 12 citations

Oxaliplatin‐induced Peripheral Neurotoxicity, Pathology, Social Sciences +16